President Trump said that the US Centers for Disease Control and Prevention had “exaggerated” its numbers, however US Surgeon General Dr. Jerome Adams stated he had “no reason to doubt” the latest figures.
As the outgoing President continues to challenge the state of Covid-19 in the U.S., the Surgeon General said that there was no ambiguity over the numbers and the figures had to be looked at, not in terms of deaths alone, but hospitalizations too.
Over the weekend, the President claimed that the CDC was using a “ridiculous method of determination” but did not provide any evidence to support his claim. The President’s claim was also countered by Dr. Anthony Fauci, who is currently in charge of the White House’s coronavirus task force.
As U.S. hospitalizations increase, many states have been running out of hospital beds, with capacity issues leading to hard choices between who gets treatment or not.
Trump in his latest statements about Covid-19 also wanted people to acknowledge his efforts saying that Fauci “works for me…and I am in no way given any credit for my work.”
As the urgency to begin vaccination takes center stage, in the final weeks of the Trump administration, there remain lingering issues with the rollout, and how states are going about their vaccination programs.
According to CNN, there were 123,639 people in hospital care nationwide with Covid related symptoms as of Saturday. It is estimated that 4 million Americans have so far received their first shot, and amid a surge in pandemic cases, there’s increased pressure on the outgoing administration to ramp up the inoculations.
The U.S. was also not alone in facing criticism for its rollout. Across Europe, nations were slow to get their vaccine programs underway. Among the slowest was France, which had only managed to administer fewer than 200 doses as of this weekend.
With nations vying for speed amid a worsening pandemic crisis, the coming days ahead could be vital for America to mitigate hospital saturation, expected in days for some states and cities.